Product description:


Vaginal probiotic medication demonstrating rapid action. inVag® is used in women to restore or supplement the vaginal bacterial flora and maintain the proper pH of the vagina. It is the best-adjusted gynaecological probiotic for Polish  women’s microflora.



Each capsule contains not less than 109 CFU (colony forming units) of lactic acid bacteria: 25% Lactobacillus fermentum 57A, 25% Lactobacillus plantarum 57B, 50% Lactobacillus gasseri 57C.

Excipients: skimmed milk powder, sucrose, sodium L-glutamate, mannitol, lactose monohydrate, magnesium stearate. Capsule ingredients: gelatin, titanium dioxide.

Instructions of use

inVag® is used in women to restore or supplement the vaginal bacterial flora and maintain the proper pH of the vagina.
The medication is recommended to use:

  • in the prevention of infections of the genitourinary system,
  • during and after treatment with antibiotics and other antibacterial and antitrichomonal and antifungal drugs,
  • during menopause and postpartum period,
  • as a preventive measure in all situations in which vaginal flora is disturbed (e.g. incorrect hygienic habits, contraception),
  • as a supporting agent in the treatment of vaginal inflammations (vaginal infections),
  • during and after treatment with antibiotics, other antibacterial and/or antifungal drugs (also during treatment of vaginal discharge).


Hypersensitivity to the active substance or to any of the excipients.


1 capsule overnight for 1 week. The treatment should be repeated when necessary. The capsule should be placed deeply in the vagina, maintaining the rules of personal hygiene.


1 blister, 7 vaginal capsules each.

Expiration date

18 months.


Store in a refrigerator (2°C – 8°C).

Pharmaceutical form

Vaginal capsule, hard.


OTC drug, issued without a prescription.

Product website

Legal information

Before using, read the leaflet, which contains indications, contraindications, data on adverse reactions and dosage, as well as information on the use of the medicinal product, or consult with a doctor or pharmacist as any drug used improperly poses a threat to your life or health.

Responsible entity and manufacturer:

Instytut Biotechnologii Surowic i Szczepionek BIOMED Spółka Akcyjna, Al. Sosnowa 8, 30-224 Kraków, Poland.

Phone: +48 12 37 69 200, Fax: +48 12 37 69 205

The page you are visiting makes use of cookies. Settings for these files can be changed in the options of browser used to browse the Internet. If you want to learn more about cookies files read the Privacy Policy.


If cookie settings are not changed, while browsing the site information will be automatically stored in the memory of your device. Do not show this message again: click here.